The Food and Drug Administration’s (FDA) announced yesterday that it would ration the late-stage cancer drug Avastin for breast cancer patients. (Ironically, the same day, the EU announced it would not ration access to Avastin.) The reaction to the FDA’s decision has been fierce:

READ MORE: http://biggovernment.com/capitolconfidential/2010/12/17/death-panels-begin-reaction-to-fdas-decision-to-begin-rationing/